AA
TYRA icon

ALPS Advisors’s Tyra Biosciences TYRA Stock Holding History

ALPS Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
60,159
+16,303
+37% +$539K 0.01% 536
2026
Q1 		$1.68M Buy
43,856
+29
+0.1% +$939 0.01% 439
2025
Q4 		$1.15M Buy
43,827
+19,127
+77% +$351K 0.01% 520
2025
Q3 		$346K Sell
24,700
-4,029
-14% -$45.9K ﹤0.01% 937
2025
Q2 		$275K Buy
+28,729
New +$273K ﹤0.01% 954

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

ALPS Advisors's TYRA Position: Q2 2026 in Review

ALPS Advisors increased its Tyra Biosciences (TYRA) stake by 37% in Q2 2026, buying an estimated $539K and bringing the position to 60,159 shares worth $1.92M. The position accounts for 0.01% of the portfolio, ranked #536.

ALPS Advisors first reported a position in TYRA in Q2 2025 and has held it in 5 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • ALPS Advisors held 60,159 shares of Tyra Biosciences worth $1.92M as of Q2 2026.
  • ALPS Advisors bought 16,303 Tyra Biosciences shares in Q2 2026, an estimated $539K.
  • Tyra Biosciences made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #536 holding.
  • ALPS Advisors first reported a position in Tyra Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.